Dr. Dale Morrison presents at ADA 2023 in San Diego
Dr. Dale Morrison, of the D.T.R.G, presents at the American Diabetes Association 2023 Scientific Sessions, in San Diego
We are very proud to have
Dr. Dale Morrison give an oral presentation at ADA 2023 presenting work from one of our exercise studies.
To reduce the risk of hypoglycemia, people with type 1 diabetes using hybrid closed loop (HCL) insulin delivery are recommended to set a temporary elevated glucose target one to two hours prior to exercise. Given this is not always feasible, this study aimed to assess hypoglycemia risk with HCL with a temporary target set at various timepoints (60 minutes prior to exercise, 20 minutes prior to exercise, at the onset of exercise, or no temporary target set).
Results indicate that a temporary target set closer to exercise (either 20 minutes prior or at exercise onset) is not inferior to current recommendations and in some cases (e.g., fasted morning exercise or vigorous exercise) promotes better glucose outcomes by limiting time spent in hyperglycemia. Setting no temporary target for long-duration aerobic exercise results in severe risk for hypoglycemia.
Setting temporary target 20 minutes prior to exercise or at exercise onset is likely more conducive to spontaneous exercise and may be a useful strategy for people with type 1 diabetes using HCL.
Dale’s focus on exercise and those living with diabetes is to be truly applauded as he seeks to find ways to best manage glycemic control both pre and post-exercise.
Dr. Dale Morrison presents at ADA 2023 in San Diego
Dr. Dale Morrison, of the D.T.R.G, presents at the American Diabetes Association 2023 Scientific Sessions, in San Diego
We are very proud to have
Dr. Dale Morrison give an oral presentation at ADA 2023 presenting work from one of our exercise studies.
To reduce the risk of hypoglycemia, people with type 1 diabetes using hybrid closed loop (HCL) insulin delivery are recommended to set a temporary elevated glucose target one to two hours prior to exercise. Given this is not always feasible, this study aimed to assess hypoglycemia risk with HCL with a temporary target set at various timepoints (60 minutes prior to exercise, 20 minutes prior to exercise, at the onset of exercise, or no temporary target set).
Results indicate that a temporary target set closer to exercise (either 20 minutes prior or at exercise onset) is not inferior to current recommendations and in some cases (e.g., fasted morning exercise or vigorous exercise) promotes better glucose outcomes by limiting time spent in hyperglycemia. Setting no temporary target for long-duration aerobic exercise results in severe risk for hypoglycemia.
Setting temporary target 20 minutes prior to exercise or at exercise onset is likely more conducive to spontaneous exercise and may be a useful strategy for people with type 1 diabetes using HCL.
Dale’s focus on exercise and those living with diabetes is to be truly applauded as he seeks to find ways to best manage glycemic control both pre and post-exercise.